BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31036057)

  • 21. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
    Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1.
    Wang Q; Wu J; Wei H; Huang H; Huang Y; Fang H; Gong X; Sun J; Wu Y; Lei C; Yu J; Hu D
    Int J Biochem Cell Biol; 2021 Sep; 138():106040. PubMed ID: 34246759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
    Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
    J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased PD-L1 Expression in Acquired Cisplatin-Resistant Lung Cancer Cells via Mir-181a.
    Chen Y; Song W; Gao Y; Dong X; Ji X
    Tohoku J Exp Med; 2022 May; 257(1):33-43. PubMed ID: 35354691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
    Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
    Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
    Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
    BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
    Xu Y; Xu Z; Li Q; Guo L; Wang Y; Zhou J; Wang G; Liu Y
    J Immunol Res; 2019; 2019():7478538. PubMed ID: 31781681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.
    Huang YJ; Yang CK; Wei PL; Huynh TT; Whang-Peng J; Meng TC; Hsiao M; Tzeng YM; Wu AT; Yen Y
    J Hematol Oncol; 2017 Feb; 10(1):60. PubMed ID: 28241877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Role of ASC, a Proapoptotic Protein, for Determining the Cisplatin Susceptibility of Lung Cancer Cells.
    Sakaizawa T; Matsumura T; Fujii C; Hida S; Toishi M; Shiina T; Yoshida K; Hamanaka K; Ito KI; Taniguchi S
    Tohoku J Exp Med; 2018 Feb; 244(2):133-144. PubMed ID: 29459573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.
    Li Y; Cao F; Li M; Li P; Yu Y; Xiang L; Xu T; Lei J; Tai YY; Zhu J; Yang B; Jiang Y; Zhang X; Duo L; Chen P; Yu X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):259. PubMed ID: 30373678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.
    Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
    Zhang Y; Du W; Chen Z; Xiang C
    Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.
    Li J; Tang Y; Tang PMK; Lv J; Huang XR; Carlsson-Skwirut C; Da Costa L; Aspesi A; Fröhlich S; Szczęśniak P; Lacher P; Klug J; Meinhardt A; Fingerle-Rowson G; Gong R; Zheng Z; Xu A; Lan HY
    Mol Ther; 2018 Oct; 26(10):2523-2532. PubMed ID: 30077612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells.
    Li Y; Chen X; He W; Xia S; Jiang X; Li X; Bai J; Li N; Chen L; Yang B
    Nutr Cancer; 2021; 73(8):1489-1497. PubMed ID: 32757802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
    Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
    J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT.
    Yu M; Zhang C; Li L; Dong S; Zhang N; Tong X
    Oncol Rep; 2014 Jun; 31(6):2751-8. PubMed ID: 24789679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma.
    Yin JZ; Shi XQ; Wang MD; Du H; Zhao XW; Li B; Yang MH
    Int Immunopharmacol; 2023 Apr; 117():109899. PubMed ID: 36827926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dasatinib promotes paclitaxel-induced necroptosis in lung adenocarcinoma with phosphorylated caspase-8 by c-Src.
    Diao Y; Ma X; Min W; Lin S; Kang H; Dai Z; Wang X; Zhao Y
    Cancer Lett; 2016 Aug; 379(1):12-23. PubMed ID: 27195913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
    Wu DW; Wu TC; Wu JY; Cheng YW; Chen YC; Lee MC; Chen CY; Lee H
    Oncogene; 2014 Aug; 33(35):4385-95. PubMed ID: 24096476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.